MEDIGEN, INC.
DNA-launched live-attenuated vaccine against Chikungunya virus (iDNA platform with genomic rearrangement for improved safety)
- Sector
- Biotech
- Total capital
- $9.7M
- Federal grants
- $2.6M
- 8 awards · 2011–2021
- Rank in peer group#391 of 514
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- $7M
- 8 awards · Health and Human S
- Rank in Biotech#70 of 4373
- Granted patents
- 6
- 10 pending · first 2017
- Rank in peer group#58 of 514
Capital timeline
Latest events
- Federal contractHealth and Human S · To Develop A Lassa Fever Vaccine$4.5M
- Federal grantHealth and Human S · Phase I · Novel Chikungunya vaccine with rearranged genome$120K
- Federal grantHealth and Human S · Phase I · Novel Chikungunya vaccine with rearranged genome$121K
- Federal contractHealth and Human S · Evaluation/titration Of Rbv Stock/vlp Manufacture$16K
- Federal grantHealth and Human S · Phase I · Multivalent emergency vaccine against pandemic influenza$95K
- Federal grantHealth and Human S · Phase I · Multivalent emergency vaccine against pandemic influenza$191K
- Federal grantHealth and Human S · Phase II · Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II$813K
Show 9 earlier federal awards
- Federal contractHealth and Human S · Igf::ot::igf Medigen, Inc. (ambis # 1808132) For Laboratory&testing Services$815K
- Federal contractHealth and Human S · Igf::ot::igf Medigen,inc. Vlp Production$28K
- Federal grantHealth and Human S · Phase II · Novel DNA-Launched Attenuated Vaccine for VEE Virus SBIR Phase II$812K
- Federal contractHealth and Human S · Igf::ot::igf Gene Expression Testing And Vaccine Production Services$61K
- Federal grantAgriculture · Polyvalent Vaccines To Protect Poultry From Avian Influenza$396K
- Federal contractHealth and Human S · Igf::ot::igf Ambis #1635093 - Preparation Of High-titer Baculovirus Stock And Vlp Expression Test.$40K
- Federal contractHealth and Human S · SBIR Topic 255, Phase II: Synthetic Vaccines Against Prostate Cancer$1.5M
- Federal grantAgriculture · Polyvalent Vaccine To Protect Poultry From Avian Influenza$100K
- Federal contractHealth and Human S · SBIR Topic 255$90K
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Standing among 514 peers
Line = medianBiotech · Molecule
- Federal grantsBelow median
- Granted patents#58 · top 11%
- Linked publications#34 · top 7%
Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.
Founders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 6 granted of 16- PendingNovel Rna And Dna Technology For Vaccination Against Alphaviruses And Other Emerging And Epidemic VirusesUSPTOApplication 18848494
- GrantedRecombinant Bovine Immunodeficiency Virus-like Particles Comprising An Influenza Ha Transmembrane Domain And C-terminusUSPTOUS 12,303,560
- PendingVaccines Against Infectious Diseases Caused By Positive Stranded Rna VirusesUSPTOApplication 18936799
Show all 16 patent records
- Novel Rna And Dna Technology For Vaccination Against Alphaviruses And Other Emerging And Epidemic VirusesJul 3, 2025 · Application 18848494Pending
- Recombinant Bovine Immunodeficiency Virus-like Particles Comprising An Influenza Ha Transmembrane Domain And C-terminusMay 20, 2025 · US 12,303,560Granted
- Vaccines Against Infectious Diseases Caused By Positive Stranded Rna VirusesFeb 20, 2025 · Application 18936799Pending
- Recombinant Bovine Immunodeficiency Virus Gag Virus-like Particles Containing Influenza ImmunogensFeb 14, 2023 · US 11,576,965Granted
- Vaccines Against Infectious Diseases Caused By Positive Stranded Rna VirusesOct 21, 2021 · Application 17357368Pending
- Vaccines Against Infectious Diseases Caused By Positive Stranded Rna VirusesJul 13, 2021 · US 11,058,759Granted
- Idna Vaccines And Methods For Using The SameMay 19, 2020 · US 10,653,769Granted
- Idna Vaccines And Methods For Using The SameMay 15, 2018 · US 9,968,672Granted
- Infectious Dna Vaccines Against Chikungunya VirusJul 4, 2017 · US 9,694,065Granted
- Infectious Dna Vaccines Against Chikungunya VirusApplication PCTUS2011000001Pending
- Emerging Novel Rna Platform Technology For Vaccination Against Chikungunya And Other Epidemic VirusesApplication 63321652Pending
- Idna Vaccines And Methods For Using The SameApplication PCTUS2009004133Pending
- Novel Rna And Dna Technology For Vaccination Against Alphaviruses And Other Emerging And Epidemic VirusesApplication PCTUS2023015581Pending
- Vaccines Against Infectious Diseases Caused By Positive Stranded Rna VirusesApplication PCTUS2017062733Pending
- Recombinant Virus Like Particles Using Bovine Immunodeficiency Virus Gag ProteinApplication PCTUS2016040838Pending
- Preparation Of Recombinant Virus-like Particles Using Bovine Immunodeficiency Virus Gag ProteinApplication 62188084Pending
Recent research by its founders
- V4020 Venezuelan Equine Encephalitis Vaccine: Mitigating Neuroinvasion and Reversion Through Rational Design20252 cites
- Safety Toxicology Study of Reassortant Mopeia–Lassa Vaccine in Guinea Pigs20251 cites
- V4020 Venezuelan Equine Encephalitis Vaccine: Mitigating Neuroinvasion and Reversion Through Rational Design20250 cites
Related companies, and why
- PROSCI, INC.Similar federal contract value in Biotech · $7.5M in contracts
- Inhibikase Therapeutics, Inc.Similar federal contract value in Biotech · $7.1M in contracts
- DYNAVAX TECHNOLOGIES CORPORATIONSimilar federal contract value in Biotech · $7.1M in contracts
- REJUVENATE BIO INCSimilar federal contract value in Biotech · $6.3M in contracts
- BCN BIOSCIENCES LLCSimilar federal contract value in Biotech · $6.2M in contracts
- PAI LIFE SCIENCES INCSimilar federal contract value in Biotech · $5.8M in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .